Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

A new oral antiviral drug for COVID is being tested in humans – can it make a difference?

By Filipa Henderson Sousa, Postdoctoral Research Fellow in Infectious Diseases, Edinburgh Napier University
Peter Barlow, Professor of Immunology and Infection, Edinburgh Napier University
Share this article
Despite the effectiveness of vaccines, we still need drugs to treat COVID. Even people who have been double vaccinated stand a small chance of getting COVID and ending up moderately or even severely ill. There are drugs to treat COVID, but they have to be given in hospital.

One promising drug that could improve things is molnupiravir, an antiviral that’s moving into the final…


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter